RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kee Moon to Lymphoma, Large B-Cell, Diffuse

This is a "connection" page, showing publications Kee Moon has written about Lymphoma, Large B-Cell, Diffuse.
Connection Strength

1.054
  1. Yang JH, Choi SJ, Won CH, Chang S, Lee MW, Huh JR, Lee KH, Choi JH, Moon KC. Paraneoplastic erythroderma: an unusual manifestation of diffuse large B-cell lymphoma. Int J Dermatol. 2013 Sep; 52(9):1149-51.
    View in: PubMed
    Score: 0.475
  2. Park GH, Kim CH, Chung WK, Won CH, Chang SE, Lee MW, Choi JH, Moon KC. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease. Acta Derm Venereol. 2010 May; 90(3):296-8.
    View in: PubMed
    Score: 0.377
  3. Lee WJ, Won KH, Won CH, Chang SE, Choi JH, Moon KC, Park CS, Huh J, Suh C, Lee MW. Secondary Cutaneous Diffuse Large B-cell Lymphoma has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-cell Lymphoma, Leg Type. Acta Derm Venereol. 2016 Feb; 96(2):245-50.
    View in: PubMed
    Score: 0.141
  4. Lee MW, Choi JH, Sung KJ, Moon KC, Koh JK. Extensive xanthelasma associated with anaplastic large cell lymphoma and hyperimmunoglobulin E syndrome. Int J Dermatol. 2003 Dec; 42(12):944-6.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support